Cargando...
Phase 1 Randomized Trial of the Vaginal Safety and Acceptability of SPL7013 Gel (VivaGel(®)) in Sexually Active Young Women (MTN-004)
OBJECTIVES: The study was designed to assess the safety, adherence, acceptability, and effect on vaginal microflora of 3% SPL7013 Gel (VivaGel(®)), a novel dendrimer topical microbicide that inhibits HIV, HSV-2 and HPV in vitro and in animal models. DESIGN: Phase 1, randomized, double-blind, placebo...
Gardado en:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2011
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3103767/ https://ncbi.nlm.nih.gov/pubmed/21505316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e328346bd3e |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|